Kazi DS - Search Results

1

Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model.

Fontil V, Bibbins-Domingo K, Kazi DS, Sidney S, Coxson PG, Khanna R, Victor RG, Pletcher MJ. Fontil V, et al. Among authors: kazi ds. J Gen Intern Med. 2015 Aug;30(8):1147-55. doi: 10.1007/s11606-015-3231-8. Epub 2015 Mar 7. J Gen Intern Med. 2015. PMID: 25749880 Free PMC article.

2

Variation in Quality of Urgent Health Care Provided During Commercial Virtual Visits.

Schoenfeld AJ, Davies JM, Marafino BJ, Dean M, DeJong C, Bardach NS, Kazi DS, Boscardin WJ, Lin GA, Duseja R, Mei YJ, Mehrotra A, Dudley RA. Schoenfeld AJ, et al. Among authors: kazi ds. JAMA Intern Med. 2016 May 1;176(5):635-42. doi: 10.1001/jamainternmed.2015.8248. JAMA Intern Med. 2016. PMID: 27042813 Free PMC article.

3

Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.

Kazi DS, Moran AE, Coxson PG, Penko J, Ollendorf DA, Pearson SD, Tice JA, Guzman D, Bibbins-Domingo K. Kazi DS, et al. JAMA. 2016 Aug 16;316(7):743-53. doi: 10.1001/jama.2016.11004. JAMA. 2016. PMID: 27533159

4

Cost-effectiveness of PCSK9 Inhibitor Therapy-Reply.

Kazi DS, Moran AE, Bibbins-Domingo K. Kazi DS, et al. JAMA. 2016 Nov 22;316(20):2152. doi: 10.1001/jama.2016.16292. JAMA. 2016. PMID: 27893125 No abstract available.

5

Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.

Kazi DS, Penko JM, Bibbins-Domingo K. Kazi DS, et al. Med Clin North Am. 2017 Jul;101(4):689-699. doi: 10.1016/j.mcna.2017.03.001. Med Clin North Am. 2017. PMID: 28577620 Review.

6

Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke.

Heller DJ, Coxson PG, Penko J, Pletcher MJ, Goldman L, Odden MC, Kazi DS, Bibbins-Domingo K. Heller DJ, et al. Among authors: kazi ds. Circulation. 2017 Sep 19;136(12):1087-1098. doi: 10.1161/CIRCULATIONAHA.117.027067. Epub 2017 Jul 7. Circulation. 2017. PMID: 28687710 Free PMC article.

7

Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial.

Kazi DS, Penko J, Coxson PG, Moran AE, Ollendorf DA, Tice JA, Bibbins-Domingo K. Kazi DS, et al. JAMA. 2017 Aug 22;318(8):748-750. doi: 10.1001/jama.2017.9924. JAMA. 2017. PMID: 28829863 Free PMC article.

8

Effect of Money-Back Guarantees on the Cost-Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors.

Kazi DS, Penko J, Ollendorf DA, Coxson PG, Bibbins-Domingo K. Kazi DS, et al. Ann Intern Med. 2018 Jun 19;168(12):896-898. doi: 10.7326/M17-3367. Epub 2018 Apr 3. Ann Intern Med. 2018. PMID: 29610832 No abstract available.

9

Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.

Kazi DS, Penko J, Coxson PG, Guzman D, Wei PC, Bibbins-Domingo K. Kazi DS, et al. Ann Intern Med. 2019 Feb 19;170(4):221-229. doi: 10.7326/M18-1776. Epub 2019 Jan 1. Ann Intern Med. 2019. PMID: 30597485

10

Does cannabis legalisation change healthcare utilisation? A population-based study using the healthcare cost and utilisation project in Colorado, USA.

Delling FN, Vittinghoff E, Dewland TA, Pletcher MJ, Olgin JE, Nah G, Aschbacher K, Fang CD, Lee ES, Fan SM, Kazi DS, Marcus GM. Delling FN, et al. Among authors: kazi ds. BMJ Open. 2019 May 15;9(5):e027432. doi: 10.1136/bmjopen-2018-027432. BMJ Open. 2019. PMID: 31092662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters